Dounel J, Lamorte C, Patton H, Perumalswami P, McCurdy H, Kim N
BMC Health Serv Res. 2025; 25(1):168.
PMID: 39875981
PMC: 11776120.
DOI: 10.1186/s12913-025-12216-8.
Haque L, Tate J, Chew M, Caniglia E, Taddei T, Lo Re 3rd V
Pharmacoepidemiol Drug Saf. 2024; 33(11):e70024.
PMID: 39477692
PMC: 11631147.
DOI: 10.1002/pds.70024.
Patel K, Zhang J, Marsden J, Bays C, Mauldin P, Schreiner A
Dig Dis Sci. 2024; 69(10):3721-3728.
PMID: 39304565
DOI: 10.1007/s10620-024-08601-8.
Lee K, Park J, Lee J, Lee M, Kim H, Son Y
Clin Mol Hepatol. 2024; 30(4):943-958.
PMID: 39205608
PMC: 11540398.
DOI: 10.3350/cmh.2024.0203.
Favre-Bulle T, Moradpour D, Marques-Vidal P, Vaucher J
BMJ Open. 2024; 14(8):e081822.
PMID: 39181561
PMC: 11344505.
DOI: 10.1136/bmjopen-2023-081822.
Patterns of gastroenterology specialty referral for primary care patients with metabolic dysfunction-associated steatotic liver disease.
Bobo J, Keith B, Marsden J, Zhang J, Schreiner A
Am J Med Sci. 2024; 368(5):455-461.
PMID: 39074780
PMC: 11490385.
DOI: 10.1016/j.amjms.2024.07.028.
The Influence of Urbanization on the Patterns of Hepatocellular Carcinoma Mortality From 1999 to 2020.
Kusnik A, Najim M, Renjith K, Vyas C, Renjithlal S, Alweis R
Gastroenterology Res. 2024; 17(3):116-125.
PMID: 38993549
PMC: 11236338.
DOI: 10.14740/gr1743.
Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation : A Nationwide Cohort Study.
Simon T, Singer D, Zhang Y, Mastrorilli J, Cervone A, DiCesare E
Ann Intern Med. 2024; 177(8):1028-1038.
PMID: 38976880
PMC: 11671173.
DOI: 10.7326/M23-3067.
A Machine Learning Algorithm Avoids Unnecessary Paracentesis for Exclusion of SBP in Cirrhosis in Resource-limited Settings.
Silvey S, Patel N, Liu J, Tafader A, Nadeem M, Dhaliwal G
Clin Gastroenterol Hepatol. 2024; 22(12):2442-2450.e8.
PMID: 38906441
PMC: 11588556.
DOI: 10.1016/j.cgh.2024.06.015.
Validating new coding algorithms to improve identification of alcohol-associated and nonalcohol-associated cirrhosis hospitalizations in administrative databases.
Swain L, Godley J, Brahmania M, Abraldes J, Tang K, Flemming J
Hepatol Commun. 2024; 8(7).
PMID: 38896072
PMC: 11186834.
DOI: 10.1097/HC9.0000000000000469.
Pour some sugar on me: Glycemic control and the prevention of liver disease.
Chen V, Flemming J
Hepatol Commun. 2024; 8(3.
PMID: 38437057
PMC: 10914224.
DOI: 10.1097/HC9.0000000000000400.
FIB-4 as a Time-varying Covariate and Its Association With Severe Liver Disease in Primary Care: A Time-dependent Cox Regression Analysis.
Schreiner A, Zhang J, Moran W, Koch D, Marsden J, Livingston S
J Clin Gastroenterol. 2023; 58(9):917-922.
PMID: 37983873
PMC: 11096263.
DOI: 10.1097/MCG.0000000000001935.
Association of Renin-Angiotensin System Inhibition With Liver-Related Events and Mortality in Compensated Cirrhosis.
Elhence H, Dodge J, Lee B
Clin Gastroenterol Hepatol. 2023; 22(2):315-323.e17.
PMID: 37495200
PMC: 11232660.
DOI: 10.1016/j.cgh.2023.07.009.
Trends in Racial and Ethnic Disparities in the Receipt of Lifesaving Procedures for Hospitalized Patients With Decompensated Cirrhosis in the US, 2009-2018.
Nephew L, Knapp S, Mohamed K, Ghabril M, Orman E, Patidar K
JAMA Netw Open. 2023; 6(7):e2324539.
PMID: 37471085
PMC: 10359964.
DOI: 10.1001/jamanetworkopen.2023.24539.
Gaps in Confirmatory Fibrosis Risk Assessment in Primary Care Patients with Nonalcoholic Fatty Liver Disease.
Moore J, Wheless W, Zhang J, Marsden J, Mauldin P, Moran W
Dig Dis Sci. 2023; 68(7):2946-2953.
PMID: 37193930
PMC: 10659111.
DOI: 10.1007/s10620-023-07959-5.
Global epidemiology of cirrhosis - aetiology, trends and predictions.
Huang D, Terrault N, Tacke F, Gluud L, Arrese M, Bugianesi E
Nat Rev Gastroenterol Hepatol. 2023; 20(6):388-398.
PMID: 36977794
PMC: 10043867.
DOI: 10.1038/s41575-023-00759-2.
Development and Validation of a Novel Tool to Predict Model for End-Stage Liver Disease (MELD) Scores in Cirrhosis, Using Administrative Datasets.
Simon T, Schneeweiss S, Wyss R, Lu Z, Bessette L, York C
Clin Epidemiol. 2023; 15:349-362.
PMID: 36941978
PMC: 10024467.
DOI: 10.2147/CLEP.S387253.
Antidiabetes medication initiation trends in US adults with cirrhosis and type 2 diabetes: A nationwide study.
Simon T, Wexler D, Schneeweiss S, Patorno E
Diabetes Obes Metab. 2023; 25(7):2028-2033.
PMID: 36938914
PMC: 10239316.
DOI: 10.1111/dom.15052.
Accurate Identification of Patients with Cirrhosis and Its Complications in the Electronic Health Record.
Khalifa A, Obeid J, Gregoski M, Rockey D
Dig Dis Sci. 2023; 68(6):2360-2369.
PMID: 36899112
PMC: 10847840.
DOI: 10.1007/s10620-023-07876-7.
Longer time to recovery from acute kidney injury is associated with major adverse kidney events in patients with cirrhosis.
Patidar K, Naved M, Kabir S, Grama A, Allegretti A, Cullaro G
Aliment Pharmacol Ther. 2023; 57(12):1397-1406.
PMID: 36883210
PMC: 10441172.
DOI: 10.1111/apt.17457.